Mark D. Sternlicht

9.1k total citations · 3 hit papers
45 papers, 7.2k citations indexed

About

Mark D. Sternlicht is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mark D. Sternlicht has authored 45 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Mark D. Sternlicht's work include Cancer Cells and Metastasis (10 papers), Protease and Inhibitor Mechanisms (10 papers) and Peptidase Inhibition and Analysis (8 papers). Mark D. Sternlicht is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Protease and Inhibitor Mechanisms (10 papers) and Peptidase Inhibition and Analysis (8 papers). Mark D. Sternlicht collaborates with scholars based in United States, Germany and United Kingdom. Mark D. Sternlicht's co-authors include Zena Werb, Hosein Kouros‐Mehr, Mina J. Bissell, Euan M. Slorach, Sanford H. Barsky, André Lochter, Joe W. Gray, Susan W. Sunnarborg, Bing Huey and Jean‐Philippe Rougier and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Mark D. Sternlicht

45 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How Matrix Metalloproteinases Regulate Cell Behavior

2001 3.2k citations Mark D. Sternlicht, Zena Werb profile →
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis

1999 722 citations Mark D. Sternlicht, André Lochter et al. Cell profile →
GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary Gland

2006 535 citations Hosein Kouros‐Mehr, Euan M. Slorach et al. Cell profile →

Peers

Mark D. Sternlicht

ONCOL

PRM

Myriam Polette France

Robert Visse United Kingdom

Thiennu H. Vu United States

Yves A. DeClerck United States

Jean‐Marie Delaissé Denmark

Marikki Laiho Finland

Paolo Mignatti United States

Milagros Balbı́n Spain

Rafael Fridman United States

Gillian Murphy United Kingdom

Myriam Polette France

Mark D. Sternlicht

2.6k ×0.9

ONCOL

2.9k ×1.0

2.5k ×0.8

875 ×1.1

PRM

959 ×1.2

Citations per year, relative to Mark D. Sternlicht Mark D. Sternlicht (= 1×) peers Myriam Polette

Countries citing papers authored by Mark D. Sternlicht

Since Specialization

Citations

This map shows the geographic impact of Mark D. Sternlicht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. Sternlicht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. Sternlicht more than expected).

Fields of papers citing papers by Mark D. Sternlicht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark D. Sternlicht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. Sternlicht. The network helps show where Mark D. Sternlicht may publish in the future.

Co-authorship network of co-authors of Mark D. Sternlicht

This figure shows the co-authorship network connecting the top 25 collaborators of Mark D. Sternlicht. A scholar is included among the top collaborators of Mark D. Sternlicht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark D. Sternlicht. Mark D. Sternlicht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bagadia, Prachi, Verónica M. Rodríguez, Mark D. Sternlicht, et al.. (2023). 1333 FG-3165 is a novel galectin-9 neutralizing antibody that inhibits galectin-9-mediated dimerization of TIM-3 and galectin-9-induced apoptosis of CD4⁺ and CD8⁺ T cells. SHILAP Revista de lepidopterología. A1484–A1484. 1 indexed citations

Seeley, Todd, Mark D. Sternlicht, Stephen J. Klaus, Thomas B. Neff, & David Y. Liu. (2017). Induction of erythropoiesis by hypoxia-inducible factor prolyl hydroxylase inhibitors without promotion of tumor initiation, progression, or metastasis in a VEGF-sensitive model of spontaneous breast cancer. PubMed. Volume 5. 1–9. 45 indexed citations

Koshman, Yevgeniya E., Mark D. Sternlicht, Taehoon Kim, et al.. (2015). Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy. Journal of Molecular and Cellular Cardiology. 89(Pt B). 214–222. 27 indexed citations

Littlepage, Laurie E., Adam S. Adler, Hosein Kouros‐Mehr, et al.. (2012). The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression. Cancer Discovery. 2(7). 638–651. 54 indexed citations

Lipson, Kenneth E., Ute Wirkner, Mark D. Sternlicht, et al.. (2011). Rapid reversal of radiation-induced murine pneumonitis by treatment with the anti-CTGF monoclonal antibody FG-3019. European Respiratory Journal. 38(Suppl 55). p668–p668. 3 indexed citations

Littlepage, Laurie E., Mark D. Sternlicht, Nathalie Rougier, et al.. (2010). Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression. Cancer Research. 70(6). 2224–2234. 169 indexed citations

Tranah, Gregory J., Brent C Taylor, Li Lui, et al.. (2008). Genetic Variation in Candidate Osteoporosis Genes, Bone Mineral Density, and Fracture Risk: The Study of Osteoporotic Fractures. Calcified Tissue International. 83(3). 155–166. 47 indexed citations

Kouros‐Mehr, Hosein, Euan M. Slorach, Mark D. Sternlicht, & Zena Werb. (2006). GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary Gland. Cell. 127(5). 1041–1055. 535 indexed citations breakdown →

Lu, Pengfei, Mark D. Sternlicht, & Zena Werb. (2006). Comparative Mechanisms of Branching Morphogenesis in Diverse Systems. Journal of Mammary Gland Biology and Neoplasia. 11(3-4). 213–228. 63 indexed citations

10.

Sternlicht, Mark D., Hosein Kouros‐Mehr, Pengfei Lu, & Zena Werb. (2006). Hormonal and local control of mammary branching morphogenesis. Differentiation. 74(7). 365–381. 233 indexed citations

11.

Sternlicht, Mark D., Susan W. Sunnarborg, Hosein Kouros‐Mehr, et al.. (2005). Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development. 132(17). 3923–3933. 242 indexed citations

12.

Sternlicht, Mark D.. (2005). Key stages in mammary gland development: The cues that regulate ductal branching morphogenesis. Breast Cancer Research. 8(1). 201–201. 276 indexed citations

13.

Lund, Leif R., Signe Frahm Bjørn, Mark D. Sternlicht, et al.. (2000). Lactational competence and involution of the mouse mammary gland require plasminogen. Development. 127(20). 4481–4492. 94 indexed citations

14.

Lochter, André, Mark D. Sternlicht, Zena Werb, & Mina J. Bissell. (1998). The Significance of Matrix Metalloproteinases during Early Stages of Tumor Progression^a. Annals of the New York Academy of Sciences. 857(1). 180–193. 104 indexed citations

15.

Barsky, Sanford H., Mark D. Sternlicht, Suzi Safarians, et al.. (1997). Evidence of a dominant transcriptional pathway which regulates an undifferentiated and complete metastatic phenotype. Oncogene. 15(17). 2077–2091. 13 indexed citations

16.

Sternlicht, Mark D. & Sanford H. Barsky. (1997). The myoepithelial defense: a host defense against cancer. Medical Hypotheses. 48(1). 37–46. 130 indexed citations

17.

Sternlicht, Mark D., Suzi Safarians, Thomas C. Calcaterra, & Sanford H. Barsky. (1996). Establishment and characterization of a novel human myoepithelial cell line and matrix-producing xenograft from a parotid basal cell adenocarcinoma. In Vitro Cellular & Developmental Biology - Animal. 32(9). 550–563. 24 indexed citations

18.

Sternlicht, Mark D., Carol J. Mirell, Suzi Safarians, & Sanford H. Barsky. (1994). A Novel Strategy for the Investigation of Clonality in Precancerous Disease States and Early Stages of Tumor Progression. Biochemical and Biophysical Research Communications. 199(2). 511–518. 13 indexed citations

19.

Sternlicht, Mark D., et al.. (1989). Renal cisplatin chemoembolization with Angiostat, Gelfoam, and Ethiodol in the rabbit: renal platinum distributions.. Radiology. 170(3). 1073–1075. 4 indexed citations

20.

Sternlicht, Mark D., et al.. (1989). Effect of antimicrobial protection on tolerance to hepatic chemoembolization with a fibrous collagen carrier.. Radiology. 170(3). 1067–1071. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact